These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 34011020

  • 1. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for iron deficiency anemia in obstetric and gynecologic patients: A systematic review and meta-analysis.
    Shin HW, Go DY, Lee SW, Choi YJ, Ko EJ, You HS, Jang YK.
    Medicine (Baltimore); 2021 May 21; 100(20):e24571. PubMed ID: 34011020
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials.
    Naqash A, Ara R, Bader GN.
    BMC Womens Health; 2018 Jan 05; 18(1):6. PubMed ID: 29304848
    [Abstract] [Full Text] [Related]

  • 3. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
    Schatz U, Illigens BM, Siepmann T, Arneth B, Siegert G, Siegels D, Heigl F, Hettich R, Ramlow W, Prophet H, Bornstein SR, Julius U.
    Atheroscler Suppl; 2015 May 05; 18():199-208. PubMed ID: 25936327
    [Abstract] [Full Text] [Related]

  • 4. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial.
    Jose A, Mahey R, Sharma JB, Bhatla N, Saxena R, Kalaivani M, Kriplani A.
    BMC Pregnancy Childbirth; 2019 Feb 04; 19(1):54. PubMed ID: 30717690
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interventions for treating iron deficiency anaemia in inflammatory bowel disease.
    Gordon M, Sinopoulou V, Iheozor-Ejiofor Z, Iqbal T, Allen P, Hoque S, Engineer J, Akobeng AK.
    Cochrane Database Syst Rev; 2021 Jan 20; 1(1):CD013529. PubMed ID: 33471939
    [Abstract] [Full Text] [Related]

  • 10. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
    Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J, FER-ASAP investigators.
    J Perinat Med; 2017 May 24; 45(4):443-453. PubMed ID: 27278921
    [Abstract] [Full Text] [Related]

  • 11. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
    Onken JE, Bregman DB, Harrington RA, Morris D, Acs P, Akright B, Barish C, Bhaskar BS, Smith-Nguyen GN, Butcher A, Koch TA, Goodnough LT.
    Transfusion; 2014 Feb 24; 54(2):306-15. PubMed ID: 23772856
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of intravenous ferric carboxymaltose in Japanese patients with iron-deficiency anemia caused by digestive diseases: an open-label, single-arm study.
    Ikuta K, Ito H, Takahashi K, Masaki S, Terauchi M, Suzuki Y.
    Int J Hematol; 2019 Jan 24; 109(1):50-58. PubMed ID: 30194568
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: A systematic review.
    Qassim A, Mol BW, Grivell RM, Grzeskowiak LE.
    Aust N Z J Obstet Gynaecol; 2018 Feb 24; 58(1):22-39. PubMed ID: 28921558
    [Abstract] [Full Text] [Related]

  • 14. A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment.
    Pollock RF, Muduma G.
    Expert Rev Hematol; 2019 Feb 24; 12(2):129-136. PubMed ID: 30689458
    [Abstract] [Full Text] [Related]

  • 15. Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron.
    Lichtenstein GR, Onken JE.
    Dig Dis Sci; 2018 Nov 24; 63(11):3009-3019. PubMed ID: 30056562
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia.
    Basha A, Ibrahim MIM, Hamad A, Chandra P, Omar NE, Abdullah MAJ, Aldapt MB, Hussein RM, Mahfouz A, Adel AA, Shwaylia HM, Ekeibed Y, AbuMousa R, Yassin MA.
    PLoS One; 2021 Nov 24; 16(8):e0255104. PubMed ID: 34375369
    [Abstract] [Full Text] [Related]

  • 17. Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis.
    Bertani L, Tricò D, Zanzi F, Baiano Svizzero G, Coppini F, de Bortoli N, Bellini M, Antonioli L, Blandizzi C, Marchi S.
    Nutrients; 2021 Feb 12; 13(2):. PubMed ID: 33673371
    [Abstract] [Full Text] [Related]

  • 18. Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.
    Mahey R, Kriplani A, Mogili KD, Bhatla N, Kachhawa G, Saxena R.
    Int J Gynaecol Obstet; 2016 Apr 12; 133(1):43-8. PubMed ID: 26868063
    [Abstract] [Full Text] [Related]

  • 19. Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulations.
    Schatz U, Arneth B, Siegert G, Siegels D, Fischer S, Julius U, Bornstein SR.
    Atheroscler Suppl; 2013 Jan 12; 14(1):115-22. PubMed ID: 23357152
    [Abstract] [Full Text] [Related]

  • 20. Role of Intravenous Ferric Carboxy-maltose in Pregnant Women with Iron Deficiency Anaemia.
    Mishra V, Gandhi K, Roy P, Hokabaj S, Shah KN.
    J Nepal Health Res Counc; 2017 Sep 08; 15(2):96-99. PubMed ID: 29016575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.